23andMe Holding Co.
ME · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | -0.09 | -0.74 |
| FCF Yield | -924.20% | -68.29% | -17.16% | -10.81% |
| EV / EBITDA | -0.32 | -0.39 | -2.62 | -5.29 |
| Quality | ||||
| ROIC | -553.10% | -116.23% | -40.11% | -24.66% |
| Gross Margin | 52.66% | 45.25% | 44.91% | 48.90% |
| Cash Conversion Ratio | 0.60 | 0.25 | 0.53 | 0.77 |
| Growth | ||||
| Revenue 3-Year CAGR | -14.09% | -6.87% | 7.08% | -3.81% |
| Free Cash Flow Growth | -1.42% | 1.54% | 2.27% | -121.50% |
| Safety | ||||
| Net Debt / EBITDA | -0.19 | 0.48 | 1.08 | 2.05 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 5.78 | 9.65 | 16.10 | 12.88 |
| Cash Conversion Cycle | 80.70 | 17.79 | -3.61 | -66.76 |